Regulation by innate immune T lymphocytes in the host defense against pulmonary infection with Cryptococcus neoformans

Japanese Journal of Infectious Diseases

Volumn 57, Issue 4, 2004, Pages 137-145

  Kawakami, Kazuyoshi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; T LYMPHOCYTE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELLULAR IMMUNITY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; LUNG MYCOSIS; MENINGOENCEPHALITIS; NATURAL KILLER CELL; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANIMALS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HUMANS; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; LUNG DISEASES, FUNGAL; MICE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES;

EID: 4644252146     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Stevens, D. A. (1990): Fungal infections in AIDS patients. Br. J. Clin. Pract., Suppl. 71, 11-22.
2. Emoto, M., Emoto. M. and Kaufmann, S. H. (2003): Liver NKT cells: an account of heterogeneity. Trends Immunol., 24, 364-369.
3. Horwitz, D. A., Gray, J. D. and Ohtsuka, K. (1999): Role of NK cells and TGF-beta in the regulation of T-cell-dependent antibody production in health and autoimmune disease. Microbes Infect., 1, 1305-1311.
4. Schaible, U. E. and Kaufmann, S. H. (2000): CD1 molecules and CD1-dependent T cells in bacterial infections: a link from innate to acquired immunity? Semin. Immunol., 12, 527-535.
5. Nishimura, T., Kitamura, H., Iwakabe, K., Yahata, T., Ohta, A., Sato, M., Takeda, K., Okumura, K., van Kaer, L., Kawano, T., Taniguchi, M., Nakui, M., Sekimoto, M. and Koda, T. (2000): The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol., 12, 987-994.
6. Feldmesser, M., Tucker, S. and Casadevall, A. (2001): Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol., 9, 273-278.
7. Lim, T. S. and Murphy, J. W. (1980): Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice. Infect. Immun., 30, 5-11.
8. Mody, C. H., Lipscomb, M. F., Street, N. E. and Toews, G. B. (1990): Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans J. Immunol., 144, 1472-1477.
9. Huffnagle, G. B., Yates, J. L. and Lipscomb, M. F. (1991): Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J. Exp. Med., 173, 793-800.
10. Hill, J. O. and Harmsen, A. G. (1991): Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells. J. Exp. Med., 173, 755-758.
11. Kawakami, K., Tohyama, M., Qifeng, X. and Saito, A. (1997): Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect. Immun., 65, 1307-1312.
12. Koguchi, Y. and Kawakami, K. (2002): Cryptococcal infection and Th1-Th2 cytokine balance. Int. Rev. Immunol., 21, 423-438.
13. Kawakami, K., Tohyama, M., Teruya, K., Kudeken, N., Xie, Q. and Saito, A. (1996): Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol. Med. Microbiol., 13, 123-130.
14. Huffnagle, G. B., Toews, G. B., Burdick, M. D., Boyd, M. B., McAllister, K. S., McDonald, R. A., Kunkel, S. L. and Strieter, R. M. (1996): Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol., 157, 4529-4536.
15. Decken, K., Kohler, G., Palmer-Lehmann, K., Wunderlin, A., Mattner, F., Magram, J., Gately, M. K. and Alber, G. (1998): Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun., 66, 4994-5000.
16. Blackstock, R., Buchanan, K. L., Adesina, A. M. and Murphy, J. W. (1999): Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates. Infect. Immun., 67, 3601-3609.
17. Trinchieri, G. (1995): Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol., 13, 251-276.
18. Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S. B., Menon, S., Kastelein, R., Bazan, F. and O'Garra, A. (1997): IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity, 7, 571-581.
19. Kawakami, K., Koguchi, Y., Qureshi, M. H., Miyazato, A., Yara, S., Kinjo, Y., Iwakura, Y., Takeda, K., Akira, S., Kurimoto, M. and Saito, A. (2000): IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells. J. Immunol., 165, 941-947.
20. Taniguchi, M. and Nakayama, T. (2000): Recognition and function of Valpha 14 NKT cells. Semin. Immunol., 12, 543-550.
21. Godfrey, D. I., Hammond, K. J. L., Poulton, L. D., Smyth, M. J. and Baxter, A. G. (2000): NKT cells: facts, functions and fallacies. Immunol. Today, 21, 573-583.
22. Kronenberg, M. and Gapin, L. (2002): The unconventional lifestyle of NKT cells. Nat. Rev. Immunol., 2, 557-568.
23. Yoshimoto, T., Bendelac, A., Watson, C., Hu-Li, J. and Paul, W. E. (1995): Role of NK1.1+T cells in a TH2 response and in immunoglobulin E production. Science, 270, 1845-1847.
24. Brown, D. R., Fowell, D. J., Corry, D. B., Wynn, T. A., Moskowitz, N. H., Cheever, A. W., Locksley, R. M. and Reiner, S. L. (1996): beta2-microglobulin-dependent NK1.1+T cells are not essential for T helper cell 2 immune responses. J. Exp. Med., 184, 1295-1304.
25. Chen, Y.-H., Chiu, N. M., Mandal, M., Wang, N. and Wang, C. R. (1997): Impaired NK1+T cell development and early IL-4 production in CD1-deficient mice. Immunity, 6, 459-467.
26. Kawano, T., Cui, J., Koezuka, Y., Toura, L, Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H. and Taniguchi, M. (1997): CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides. Science, 278, 1626-1629.
27. Burdin, N., Brossay, L., Koezuka, Y., Smiley, S. T., Grusby, M. J., Taniguchi, M., Hayakawa, K. and Kronenburg, M. (1998): Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates Valpha14 NK T lymphocytes. J. Immunol., 161, 3271-3281.
28. Lehuen, A., Lantz, O., Beaudoin, L., Laloux, V., Carnaud, C., Bendelac, A., Bach, J. F. and Monteiro, R. C. (1998): Overexpression of natural killer T cells protects Valpha 14- Jalpha281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med., 188, 1831-1839.
29. Singh, N., Hong, S., Scherer, D. C., Serizawa, I., Burdin, N., Kronenberg, M., Koezuka, Y. and van Kaer, L. (1999): Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol., 163, 2373-2377.
30. Carnaud, C., Lee, D., Donnars, O., Park, S. H., Beavis, A., Koezuka, Y. and Bendelac, A. (1999): Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol., 163, 4647-4650.
31. Cui, J., Watanabe, N., Kawano, T., Yamashita, M., Kamata, T., Shimizu, C., Kimura, M., Shimizu, E., Oike, J., Koseki, H., Tanaka, Y., Taniguchi, M. and Nakayama, T. (1999): Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer cells. J. Exp. Med., 190, 783-792.
32. Apostolou, I., Takahama, Y., Belmant, C., Kawano, T., Huerre, M., Marchal, G., Cui, J., Taniguchi, M., Nakauchi, H., Fournie, J.-J., Kourilsky, P. and Gachelin, G. (1999): Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc. Natl. Acad. Sci. USA, 96, 5141-5146.
33. Gonzalez-Aseguinolaza, G., de Oliveira, C., Tomsaka, M., Hong, S., Bruna-Romero, O., Nakayama, T., Taniguchi, M., Bendelac, A., van Kaer, L., Koezuka, Y. and Tsuji, M. (2000): alpha-galactosylceramide-activated Valpha14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA, 97, 8461-8466.
34. Kawakami, K., Kinjo, Y., Uezu, K., Yara, S., Miyagi, K., Koguchi, Y., Nakayama, T., Taniguchi, M. and Saito, A. (2002): Minimal contribution of Valpha14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice. Microbiol. Immunol., 46, 207-210.
35. Sousa, A. O., Mazzaccaro, R. J., Russell, R. G., Lee, F. K., Turner, O. C., Hong, S., van Kaer, L. and Bloom, B. R. (2000): Relative contributions of distinct MHC class 1-dependent cell populations in protection to tuberculosis infection in mice. Proc. Natl. Acad. Sci. USA, 97, 4204-4208.
36. Szalay, G., Zugel, U., Ladel, C. H. and Kaufmann, S. H. E. (1999): Participation of group 2 CD1 molecules in the control of murine tuberculosis. Microb. Infect., 1, 1153-1157.
37. Ishigami, M., Nishimura, H., Naiki, Y., Yoshioka, K., Kawano, T., Tanaka, Y., Taniguchi, M., Kakumu, S. and Yoshikai, Y. (1999): The roles of intrahepatic Valpha14+ NK1.1+T cells for liver injury induced by Salmonella infection in mice. Hepatology, 29, 1799-1808.
38. Szalay, G., Ladel, C. H., Blum, C., Brossay, L., Kronenberg, M. and Kaufmann, S. H. E. (1999): Anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-beta2 and Th1 cytokines and ameliorates listeriosis in mice. J. Immunol., 162, 6955-6958.
39. Nakano, Y., Hisaeda, H., Sakai, T., Zhang, M., Maekawa, Y., Zhang, T. and Himeno, K. (2001): Role of innate immune cells in protection against Toxoplasma gondii at inflamed site. J. Med. Invest., 48, 73-80.
40. Kawakami, K., Yamamoto, N., Kinjo, Y., Miyagi, K., Nakasone, C., Uezu, K., Kinjo, T., Nakayama, T., Taniguchi, M. and Saito, A. (2003): Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur. J. Immunol., 33, 3322-3330.
41. Ishikawa, H., Hisaeda, H., Taniguchi, M., Nakayama, T., Sakai, T., Maekawa, Y., Nakano, Y., Zhang, M., Zhang, T., Nishitani, M., Takashima, M. and Himeno, K. (2000): CD4+ Valpha14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int. Immunol., 12, 1267-1274.
42. Duthie, M. S., Wleklinski-Lee, M., Smith, S., Nakayama, T., Taniguchi, M. and Kahn, S. J. (2002): During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Infect. Immun., 70, 36-48.
43. Nieuwenhuis, E. E., Matsumoto, T., Exley, M., Schleipman, R. A., Glickman, J., Bailey, D. T., Corazza, N., Colgan, S. P., Onderdonk, A. B. and Blumberg, R. S. (2002): CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med., 8, 588-593.
44. Kumar, H., Belperron, A., Barthold, S. W. and Bockenstedt, L. K. (2000): CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J. Immunol., 165, 4797-4801.
45. - subsets of intermediate TCR cells which are constituents of innate immunity. Cell. Immunol., 211, 96-104.
46. Kawakami, K., Kinjo, Y., Uezu, K., Yara, S., Miyagi, K., Koguchi, Y., Nakayama, T., Taniguchi, M. and Saito, A. (2001): Monocyte chemoattractant protein-1-dependent increase of Valpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J. Immunol., 167, 6525-6532.
47. Rossi, D. and Zlotnik, A. (2000): The biology of chemokines and their receptors. Annu. Rev. Immunol., 217, 217-242.
48. Maghazachi, A. A., Skalhegg, B. S., Rolstad, B. and Al-Aoukaty, A. (1997): Interferon-inducible protei-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins. FASEB J., 11, 765-774.
49. Taub, D. D., Sayers, T. J., Carter, C. R. and Ortaldo, J. R. (1995): Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol., 155, 3877-3888.
50. Allavena, P., Bianchi, G., Zhou, D., van Damme, J., Jilek, P., Sozzani, S. and Mantovani, A. (1994): Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur. J. Immunol., 24, 3233-3236.
51. Maghazachi, A. A., Al-Aoukaty, A. and Schall, T. J. (1994): C-C chemokine induce the chemotaxis of NK and IL-2-activated NK cells. Role for G-proteins. J. Immunol., 153, 4969-4977.
52. 2+ mobilization, and enzyme release. J. Immunol., 156, 322-327.
53. Giancarlo, B., Silvano, S., Albert, Z., Mantovani, A. and Allavena, P. (1996): Migratory response of human natural killer cells to lymphotactin. Eur. J. Immunol., 26, 3238-3241.
54. Faunce, D. E., Sonoda, K. and Stein-Streilein, J. (2001): MIP-2 recruits NKT cells to the spleen during tolerance induction. J. Immunol., 166, 313-321.
55. Joyce, S., Woods, A. S., Yewdell, J. W., Bennink, J. R., de Silva, A. D., Boesteanu, A., Balk, S. P., Cotter, R. J. and Brutkiewicz, R. R. (1998): Natural ligand of mouse CD1d: cellular glycosylphosphatidyl-inositol. Science, 279, 1541-1544.
56. Schofield, L., McConville, M. J., Hansen, D., Campbell, A. S., Fraser-Reid, B., Grusby, M. J. and Tachado, S. D. (1999): CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science, 283, 225-229.
57. Molano, A., Park, S. H., Chiu, Y. H., Nosseir, S., Bendelac, A. and Tsuji, M. (2000): Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and anti-malarial responses. J. Immunol., 164, 5005-5009.
58. Procopio, D. O., Almeida, I. C., Torrecilhas, A. C., Cardoso, J. E., Teyton, L., Travassos, L. R., Bendelac, A. and Gazzinelli, R. T. (2002): Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway. J. Immunol., 169, 3926-3933.
59. Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E. and Brenner, M. B. (2003): Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol., 4, 1230-1237.
60. Toura, I., Kawano, T., Akutsu, Y., Nakayama, T., Ochiai, T. and Taniguchi, M. (1999): Inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. J. Immunol., 163, 2387-2391.
61. Gonzalez-Aseguinolaza, G., Van Kaer, L., Bergmann, C. C., Wilson, J. M., Schmieg, J., Kronenberg, M., Nakayama, T., Taniguchi, M., Koezuka, Y. and Tsuji, M. (2002): Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med., 195, 617-624.
62. Kawakami, K., Kinjo, Y., Yara, S., Koguchi, Y., Uezu, K., Nakayama, T., Taniguchi, M. and Saito, A. (2001): Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect. Immun., 69, 213-220.
63. Kawakami, K., Kinjo, Y., Yara, S., Uezu, K., Koguchi, Y., Tohyama, M., Azuma, M., Takeda, K., Akira, S. and Saito, A. (2001): Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis. Infect. Immun., 69, 6643-6650.
64. Chackerian, A., Alt, J., Perera, V. and Behar, S. M. (2002): Activation of NKT cells protects mice from tuberculosis. Infect. Immun., 70, 6302-6309.
65. Hayday, A. C. (2000): Gamma/delta cells: a right time and a right place for a conserved third way of protection. Annu. Rev. Immunol., 18, 975-1026.
66. Lahn, M. (2000): The role of gamma/delta T cells in the airways. J. Mol. Med., 78, 409-425.
67. Augustin, A., Kubo, R. T. and Sim, G. K. (1989): Resident pulmonary lymphocytes expressing the gamma/delta T-cell receptor. Nature, 340, 239-241.
68. Hayes, S. M., Sirr, A., Jacob, S., Sim, G. K. and Augustin, A. (1996): Role of IL-7 in the shaping of the pulmonary gamma delta T cell repertoire. J. Immunol., 156, 2723-2729.
69. Sim, G. K., Rajaserkar, R., Dessing, M. and Augustin, A. (1994): Homing and in situ differentiation of resident pulmonary lymphocytes. Int. Immunol., 6, 1287-1295.
70. Tanaka, Y., Morita, C. T., Tanaka, Y., Nieves, E., Brenner, M. B. and Bloom, B. R. (1995): Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature, 375, 155-158.
71. Bukowski, J. F., Morita, C. T. and Brenner, M. B. (1999): Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity, 11, 57-65.
72. Holoshitz, J., Vila, L. M., Keroack, B. J., McKinley, D. R. and Bayne, N. K. (1992): Dual antigenic recognition by cloned human gamma delta T cells. J. Clin. Invest., 89, 308-314.
73. O'Brien, R. L., Happ, M. P., Dallas, A., Palmer, E., Kubo, R. and Born, W. K. (1989): Stimulation of a major subset of lymphocytes expressing T cell receptor gamma delta by an antigen derived from Mycobacterium tuberculosis. Cell, 57, 667-674.
74. Born, W., Hall, L., Dallas, A., Boymel, J., Shinnick, T., Young, D., Brennan, P. and O'Brien, R. (1990): Recognition of a peptide antigen by heat shock-reactive gamma delta T lymphocytes. Science, 249, 67-69.
75. O'Brien, R. L., Fu, Y. X., Cranfill, R., Dallas, A., Ellis, C., Reardon, C., Lang, J., Carding, S. R., Kubo, R. and Born, W. (1992): Heat shock protein Hsp60-reactive gamma delta cells: a large, diversified T-lymphocyte subset with highly focused specificity. Proc. Natl. Acad. Sci. USA, 89, 4348-4352.
76. Janeway, C. A. Jr., Jones, B. and Hayday, A. (1988): Specificity and function of T cells bearing gamma delta receptors. Immunol. Today, 9, 73-76.
77. Porcelli, S., Brenner, M. B. and Band, H. (1991): Biology of the human gamma delta T-cell receptor. Immunol. Rev., 120, 137-183.
78. Morita, C. T., Verma, S., Aparicio, P., Martinez, C., Spits, H. and Brenner. M. B. (1991): Functionally distinct subsets of human gamma/delta T cells. Eur. J. Immunol., 21, 2999-3007.
79. - gamma delta-T cells recovered from mice with influenza pneumonia. J. Immunol., 147, 2069-2074.
80. Taguchi, T., Aicher, W. K., Fujihashi, K., Yamamoto, M., McGhee, J. R., Bluestone, J. A. and Kiyono, H. (1991): Novel function for intestinal intraepithelial lymphocytes. Murine CD3+, gamma/delta TCR+ T cells produce IFN-gamma and IL-5. J. Immunol., 147, 3736-3744.
81. Bluestone, J. A., Cron, R. Q., Barrett, T. A., Houlden, B., Sperling, A. I., Dent, A., Hedrick, S., Rellahan, B. and Matis, L. A. (1991): Repertoire development and ligand specificity of murine TCR gamma delta cells. Immunol. Rev., 120, 5-33.
82. Ferrick, D. A., Schrenzel, M. D., Mulvania, T., Hsieh, B., Ferlin, W. G. and Lepper, H. (1995): Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature, 373, 255-257.
83. Roessner, K., Wolfe, J., Shi, C., Sigal, L. H., Huber, S. and Budd, R. C. (2003): High expression of Fas ligand by synovial fluid-derived gamma delta T cells in Lyme arthritis. J. Immunol., 170, 2702-2710.
84. Moore, T. A., Moore, B. B., Newstead, M. W. and Standiford, T. J. (2000): Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumoniae. J. Immunol., 165, 2643-2650.
85. Takano, M., Nishimura, H., Kimura, Y., Mokuno, Y., Washizu, J., Itohara, S., Nimura, Y. and Yoshikai, Y. (1998): Protective roles of gamma delta T cells and interleukin-15 in Escherichia coli infection in mice. Infect. Immun., 66, 3270-3278.
86. Hiromatsu, K., Yoshikai, Y., Matsuzaki, G., Ohga, S., Muramori, K., Matsumoto, K., Bluestone, J. A. and Nomoto, K. (1992): A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice. J. Exp. Med., 175, 49-56.
87. Ladel, C. H., Blum, C., Dreher, A., Reifenberg, K. and Kaufmann, S. H. ( 1995): Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis. Eur. J. Immunol., 25, 2877-2881.
88. King, D. P., Hyde, D. M., Jackson, K. A., Novosad, D. M., Ellis, T. N., Putney, L., Stovall, M. Y., van Winkle, L. S., Beaman, B. L. and Ferrick, D.A. (1999): Cutting edge: protective response to pulmonary injury requires gamma delta T lymphocytes. J. Immunol., 162, 5033-5036.
89. Jones-Carson, J., Vazquez-Torres, A., van der Heyde, H. C., Warner, T., Wagner, R. D. and Balish, E. (1995): Gamma delta T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nat. Med., 1, 552-557.
90. Rosat, J. P., MacDonald, H. R. and Louis, J. A. (1993): A role for gamma delta + T cells during experimental infection of mice with Leishmania major. J. Immunol., 150, 550-555.
91. Hisaeda, H., Nagasawa, H., Maeda, K., Maekawa, Y., Ishikawa, H., Ito, Y., Good, R. A. and Himeno, K. (1995): Gamma delta T cells play an important role in hsp65 expression and in acquiring protective immune responses against infection with Toxoplasma gondii. J. Immunol., 155, 244-251.
92. O'Brien, R. L., Yin, X., Huber, S. A., Ikuta, K. and Born, W. K. (2000): Depletion of a gamma delta T cell subset can increase host resistance to a bacterial infection. J. Immunol., 165, 6472-6479.
93. Emoto, M., Nishimura, H., Sakai, T., Hiromatsu, K., Gomi, H., Itohara, S. and Yoshikai, Y. (1995): Mice deficient in gamma delta T cells are resistant to lethal infection with Salmonella choleraesuis. Infect. Immun., 63, 3736-3738.
94. Wormley, F. L. Jr., Steele, C., Wozniak, K., Fujihashi, K., McGhee, J. R. and Fidel, P. L. Jr. (2001): Resistance of T-cell receptor delta-chain-deficient mice to experimental Candida albicans vaginitis. Infect. Immun., 69, 7162-7164.
95. Williams, D. M., Grubbs, B. G., Kelly, K., Pack, E. and Rank, R. G. (1996): Role of gamma-delta T cells in murine Chlamydia trachomatis infection. Infect. Immun., 64, 3916-3919.
96. Uezu, K., Kawakami, K., Miyagi, K., Kinjo, Y., Kinjo, T., Ishikawa, H. and Saito, A. (2004): Accumulation of gammadelta T cells in the lungs and their regulatory roles in Th1 response and host defense against pulmonary infection with Cryptococcus neoformans. J. Immunol., 172, 7629-7634.
97. Wesch, D., Glatzel, A. and Kabelitz, D. (2001): Differentiation of resting human peripheral blood gamma delta T cells toward Th1- or Th2-phenotype. Cell. Immunol., 212, 110-117.
98. Nagaeva, O., Jonsson, L. and Mincheva-Nilsson, L. (2002): Dominant IL-10 and TGF-beta mRNA expression in gamma delta T cells of human early pregnancy decidua suggests immunoregulatory potential. Am. J. Reprod. Immunol., 48, 9-17.
99. Reed, S. G. (1999): TGF-beta in infections and infectious diseases. Microbes Infect., 1, 1313-1325.
100. Letterio, J. J. and Roberts, A. B. (1998): Regulation of immune responses by TGF-beta. Annu. Rev. Immunol., 16, 137-161.
101. Hirsch, C. S., Ellner, J. J., Blinkhorn, R. and Toossi, Z. (1997): In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc. Natl. Acad. Sci. USA, 94, 3926-3931.
102. Li, J., Hunter, C. A. and Farrell, J. P. (1999): Anti-TGF-beta treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. J. Immunol., 162, 974-979.